Ticker Details
Neumora Therapeutics, Inc.
IPO Date:	September 15, 2023
Sector:	Healthcare
Industry:	Biotech
Market Cap:	$342.78M
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$0.24 | 3.77%
Avg Daily Range (30 D):	$0.08 | 3.97%
Avg Daily Range (90 D):	$0.09 | 3.82%

Institutional Daily Volume
Avg Daily Volume:	1.09M
Avg Daily Volume (30 D):	1.36M
Avg Daily Volume (90 D):	1.31M

Trade Size
Avg Trade Size (Sh.):	152
Avg Trade Size (Sh.) (30 D):	162
Avg Trade Size (Sh.) (90 D):	168

Institutional Trades
Total Institutional Trades:	301
Avg Institutional Trade:	$1.86M
Avg Institutional Trade (30 D):	$.73M
Avg Institutional Trade (90 D):	$2.67M
Avg Institutional Trade Volume:	.24M
Avg Institutional Trades (Per Day):	1

Market Closing Trades
Avg Closing Trade:	$2.34M
Avg Closing Trade (30 D):	$5.12M
Avg Closing Trade (90 D):	$5.12M
Avg Closing Volume:	292.74K

News

Mar 19, 2026 @ 11:27 PM NMRA Investors Have Opportunity to Join Neumora Th... Source: Schall Law Firm

Mar 16, 2026 @ 11:00 AM Neumora Therapeutics to Report Fourth Quarter and ... Source: Na

Feb 4, 2026 @ 12:00 PM Neumora Therapeutics to Participate in Gugge... Source: Na

Nov 18, 2025 @ 6:02 PM Top 3 Biotech Stocks Capitalizing on the AI Revolu... Source: Timothy Fries

Oct 1, 2025 @ 11:00 AM Neumora Therapeutics to Host Virtual R&D Day on Oc... Source: Helen Rubinstein

Financials
	TTM	Q1 2026	Q4 2025
Basic EPS	$-1.33	$-.3	$-.35
Diluted EPS	$-1.33	$-.3	$-.35
Revenue	$M	$M	$M
Gross Profit
Net Income / Loss	$-222.39M	$-53.46M	$-59.45M
Operating Income / Loss	$-223.08M	$-52.86M	$-58.48M
Cost of Revenue
Net Cash Flow	$3.71M	$-35.46M	$53.46M
PE Ratio